Canada House Wellness Group Inc. - 500 Beiträge pro Seite

[praesens]

Hallo,

ich möchte hier die Canada House Wellness Group Inc. vorstellen.

website: https://canadahouse.ca/

CHW ist ein seit September 2017 durch Health Canada lizensiertes Unternehmen -
bzw. die Lizenz hat die Tochter abba medix inne:

http://abbamedix.com/

"License status: Received cultivation license"

Auf HC - 2. von oben:

https://www.canada.ca/en/health-canada/services/drugs-health…


Daneben gibt es noch die Töchter

Marijuana For Trauma Inc.
https://mftgroup.ca/

und

Knalysis Technologies
http://knalysis.com/

[praesens]

Antwort auf Beitrag Nr.: 56.522.741 von praesens am 21.12.17 21:41:03

Allerdings bereits 120 mio ausgegebene Aktien.
Dazu kommen ca. 46 mo ausstehende options und warrants, macht also in der Summe ca. 166 mio fully diluted.

Aktueller Kurs: 0,46 $ = marketcap ca. 76 mio $ (noch ...)

[praesens]

Antwort auf Beitrag Nr.: 56.522.795 von praesens am 21.12.17 21:46:01

Hier findet ihr Umsatz- und Gewinnprognosen für die kommenden Jahre.

Liest sich gut - aber sind auch nur Prognosen seitens der Firma:

https://canadahouse.ca/financial-information/

[praesens]

Antwort auf Beitrag Nr.: 56.522.813 von praesens am 21.12.17 21:47:53

Im Folgenden drei Kurz-Zusammenfassungen zu den 3 Töchtern.
Quelle jeweils homepage.


Marijuana for Trauma Cannabis Wellness Clinics

MFT’s range of services to its clients includes:

• Documentation of a client’s medical history and current condition; • Evaluation of their current condition and meds taken; • Discussion of possible cannabis alternatives to consider;

• Assistance in obtaining a medical cannabis prescription;

• Assistance in identifying a “best fit” cannabis strain and vendor selection;

• Evaluation of treatment results, with the objective of establishing each client’s optimum benefit routine; and

• Counseling on how a client can take full advantage of any insurance and disability benefits that may be available.

As MFT has grown, so have its number of civilian clients, who now constitute approximately 50% of those it serves.

[praesens]

Antwort auf Beitrag Nr.: 56.522.828 von praesens am 21.12.17 21:49:40

Knalysis Technologies Data Analytics

It created its smartphone Wellness Tracker to provide an essential treatment-results-treatment refinement feedback loop to refine its data sets.

For its sister company, MFT, it created its HIPPA-compliant Cannabis Patient Management software that seamlessly links MFT with its patients, physicians, and other care providers, a global approach to reporting, monitoring and care.
Its leadership team envisioned a need for health technology connecting every aspect of the medical marijuana field, and has pioneered software developed to deliver better monitoring of symptoms, moods, and treatments for both physician and patient. Knalysis principals are industry veterans in technology, data collection, business applications, and the medical marijuana vertical.

Its team is made up of elites in IT with resumes that includes substantial work for Microsoft, Boeing, IBM, CERN, McAfee, Bank of America, and other international organizations.

[praesens]

Antwort auf Beitrag Nr.: 56.522.828 von praesens am 21.12.17 21:49:40

Abba Medix Craft Cannabis Licensed Producer

Abba projects that it will complete its required two grow cycles and will have received its License to Sell and be fully operational by the end of Q1 2018, at a cost of approximately $5 million, a significant portion of which is already in place.

Abba will then offer a fully integrated seed to sale vertical with the benefit of an API that will link directly to the Cannabis Patient Management patient services and software provided by its sister company, Marijuana for Trauma – now with more than 7,000 active clients.

[praesens]

Antwort auf Beitrag Nr.: 56.522.834 von praesens am 21.12.17 21:50:35

Aktuell läuft eine Finanzierung über convertible debentures:

https://canadahouse.ca/2017/11/07/canada-house-wellness-grou…

"Canada House Wellness Group Announces Convertible Debenture Unit Financing for $2 to $4 Million

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

TORONTO, Nov. 06, 2017 (GLOBE NEWSWIRE) — Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) announces that it intends to proceed with a financing of unsecured convertible debenture units for total gross proceeds to the Company of $2,000,000 to $4,000,000 (the “Offering”).

Each Unit is comprised of: (i) $1,000 principal amount of 8.5% unsecured convertible debentures (“Convertible Debentures“) in the capital of the Company with a maturity date (“Maturity Date“) of four years from the date of issuance; and (ii) 5,263 detachable common share purchase warrants of the Company (each, a “Warrant“).

Each Convertible Debenture shall be convertible at the holder’s option into fully-paid common shares of the Company (each, a “CD Share”) at any time prior to the Maturity Date at a conversion price of $0.19 per Common Share if converted within the first 12 months following the Closing Date and at a conversion price of $0.40 per Common Share if converted at any time following the date that is 12 months and one day following the closing date of the Offering, being a ratio initially of 5,263 CD Shares per $1,000 principal amount of Convertible Debentures.

Each Warrant shall be exercisable into one common share of the Company (each, a “CD Warrant Share“) at an exercise price of $0.30 for a period of 12 months; at an exercise price of $0.40 from 12 months to 24 months; at an exercise price of $0.60 from 24 months to 36 months; and at an exercise price of $0.80 from 36 months to 48 months following the closing date of the Offering.

The Company may pay to an appropriately registered entity a cash commission of up to 8.0% of the aggregate gross proceeds from subscriptions from investors introduced to the Company by such finder and, subject to regulatory approval (where any such approval is required), warrants having terms substantially similar to the Warrants, to acquire from treasury an amount of common shares equal to up to 8.0% of the gross proceeds arising from subscriptions introduced to the Company by such finder.

The private placement details and subscription agreement also will be available to investors in the Stockhouse Deal Room (http://www.stockhouse.com/dealroom). The Stockhouse Deal Room is an equity investment platform created specifically for public companies to access investors. Stockhouse has more than 1 million unique visitors a month and provides access to a large number of qualified and accredited investors. Subscription agreements can be completed in full through Stockhouse Deal Room or are available directly from the Company to “Accredited Investors” (as defined in National Instrument 45-106 – Prospectus Exemptions).

The proceeds from the financing are expected to be used to provide capital for improvements and equipment at the Abba Medix grow facility; clinic expansion capital for the Company’s Marijuana For Trauma division; R&D capital for its Knalysis Technologies division; support of MFT’s new client acquisition program implementation; towards the repayment of debt; and for general working capital purposes.

Closing of the Offering is subject to the Company obtaining all necessary regulatory and stock exchange approvals and subject to the revocation of the management cease trade order issued by the Ontario Securities Commission in respect of the Company’s securities. The Convertible Debentures and Warrants issued pursuant to the Offering, and any common shares issued on the conversion of the Convertible Debentures or exercise of the Warrants will be subject to a statutory hold period in Canada of four months and one day following the closing of the Offering in accordance with applicable securities laws. Additional resale restriction may be applicable under the laws of other jurisdictions, if any.

Certain subscribers under the Offering may be “related parties” to the Company and, accordingly, the Offering may be deemed to be a “related party transaction” as defined under Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions(“MI 61-101”).

Other than subscription agreements between such related parties and the Company relating to the issuance of the Units pursuant to the Offering, the Company has not entered into any agreement with an interested party or a joint actor with an interested party in connection with the Offering.

The Company expects that the Offering will be exempt from the formal valuation and minority shareholder approval requirements of MI 61-101 (pursuant to subsections 5.5(a) and 5.7(1)(a)) as the fair market value of the related party transactions are not expected to be more than 25% of the market capitalization of the Company. The material change report in connection with the Private Placement was not filed 21 days in advance of the closing of the Private Placement for the purposes of Section 5.2(2) of MI 61-101 on the basis that the funds of the Private Placement are urgently required by the Company to address working capital requirements.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein, and these securities will not be offered or sold in any jurisdiction in which their offer or sale would be unlawful. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “1933 Act”), or any state securities laws of the United States. Accordingly, these securities will not be offered or sold to persons within the United States unless an exemption from the registration requirements of the 1933 Act and applicable state securities laws is available."

[praesens]

Antwort auf Beitrag Nr.: 56.522.882 von praesens am 21.12.17 21:54:00

Die laufzeit der Finanzierung wurde verlängert, da man die angedachten 4 mio wohl vollmachen kann:

https://globenewswire.com/news-release/2017/11/27/1206300/0/…

[praesens]

Antwort auf Beitrag Nr.: 56.522.894 von praesens am 21.12.17 21:55:37

Das Geschäftsmodell bildlich dargestellt:

[praesens]

Antwort auf Beitrag Nr.: 56.522.930 von praesens am 21.12.17 21:58:26

ABBA MEDIX CORP.

AN IN-HOUSE CULTIVATION DIVISION PROVIDING CANNABIS CRAFTED TO MFT’S CLIENTS’ NEEDS.
Having been recently awarded its License to Cultivate from Health Canada, our Abba Medix division, based in Pickering, ON, will be producing “craft cannabis” from its 49,500 sf facility, as well as a range of tinctures and extracts, beginning in the 1st quarter of 2018.


MARIJUANA FOR TRAUMA

ONBOARDING OVER 500 NEW CLIENTS EVERY MONTH.
MFT owns and operates 11 cannabis coaching clinics throughout Canada, serving currently over 7,000 active clients. Its mission is to help our clientele determine how best they can replace harmful prescriptions with medical cannabis.


KNALYSIS TECHNOLOGIES

TRACKING, PROVING AND OPTIMIZING THE EFFICACY OF MEDICAL MARIJUANA.
KT’s suite of fully-customizable, cloud-based software benefits patients, clinics, dispensaries and growers by arming them with the data information they need to determine what products and strains to take, prescribe, stock and grow.
Knalysis closes the data loop by quantifying what is truly working for patients treating their symptoms with cannabis.


Quelle: hompage (vorheriges post auch)

[praesens]

Antwort auf Beitrag Nr.: 56.522.960 von praesens am 21.12.17 22:01:06

Kontaktdaten:

Head Office
Canada House Wellness Group Inc.
1773 Bayly Street
Pickering, ON L1W 2Y7
Email: [e-mail]
Phone: [phone]
Fax: [phone]

[praesens]

Antwort auf Beitrag Nr.: 56.522.960 von praesens am 21.12.17 22:01:06

Präsentation:

https://canadahouse.ca/wp-content/uploads/2017/05/170515-CH-…

[praesens]

Antwort auf Beitrag Nr.: 56.522.960 von praesens am 21.12.17 22:01:06

Chart:

[praesens]

Antwort auf Beitrag Nr.: 56.522.999 von praesens am 21.12.17 22:04:49

Listing in Kanada an der CSE unter dem Symbol CHV

Deutsche WKN A2DGL2, listing in Stuttgart

[praesens]

Antwort auf Beitrag Nr.: 56.523.020 von praesens am 21.12.17 22:06:23

Gehandelt heute über 6,5 mio Stücke.
SK 0,445 dollar = +22%

Gruß, praesens

[Saftschubsee]

Grüß dich praesens ,

erstmal möchte ich mich bei dir für eine weitere sehr gute Vorstellung eine Aktie bedanken.
Finde das sich das eigtl ziemlich gut liest.
Mir ist nur nicht ganz klar geworden ob abbamedix Cannabis verkauft oder nur die Seeds?
Schöne Grüße Saft

[praesens]

Antwort auf Beitrag Nr.: 56.523.755 von Saftschubsee am 21.12.17 23:48:54

Hi Saft,

noch wird nichts verkauft.
Die sales license wird für Q1 2018 erwartet.
Bis dahin müssen erst einmal 2 Ernten eingebracht werden (Erzeugung von Klonen).
Erst mit der dritten Ernte kann dann tatsächlich Umsatz erzielt werden.
Bisher werden den Patienten Produkte anderer Unternehmen anempfohlen.

Gruß und Gute Nacht,
praesens

[Saftschubsee]

Antwort auf Beitrag Nr.: 56.523.806 von praesens am 22.12.17 00:09:31

Cool, danke für das schnelle Feedback.

[Opa_Klaus]

Danke praesens für die ausführliche Vorstellung. Wenn die Firma/ Töchter ihre Vorgaben auch so einhalten wird der Kurs nur eine Richtung kennen.

[Saftschubsee]

Jo Leute wie ich so eben feststellen musste ist es mit meiner Bank (OnVista Bank) in Zukunft und auch jetzt schon nicht mehr möglich solche Wertpapiere ( Kanadische, Amerikanische Penny Stocks) zuhandeln und zu verwahren. Nach einem Telefonat mit OnVista meinte er das OnVista nicht die einzige Bank sei die sich eben gegen den Handel etc von Penny Stocks entschieden habe und dass das bei den meisten Banken bis spätestens mitte nächsten Jahres unterbunden wird.
Ypso facto suche ich jetzt einen neuen Broker. Wollte ich mal fragen bei welchem Broker ihr seit und ob ihr iwas davon wisst das der Handel und die Verwahrung bei eurem Broker in Zukunft stopt ?

[Opa_Klaus]

Antwort auf Beitrag Nr.: 56.527.763 von Saftschubsee am 22.12.17 12:05:40

Höre hier in Deutschland zum ersten Mal davon.

Scheint aber in Österreich bereits 2015 ein Thema gewesen zu sein.

https://www.trend.at/newsticker/banken-handel-pennystocks-54…

Bei meiner ING-DiBa habe ich bisher noch keine Hinweise diesbezüglich erhalten. Bin dort eigentlich sehr zufrieden. Schnelle Orderausführungen und auch Handel in Kanada ist kein Problem. Nur Order an der ASX sind nicht möglich.

[praesens]

Antwort auf Beitrag Nr.: 56.527.763 von Saftschubsee am 22.12.17 12:05:40

Kann mich OpaKlaus da nur anschliessen.
Kenne das Thema aus Österreich und von einigen deutschen Häusern.
Bin selbst bei comdirect (habe da keine Probleme (nur OTC gedht nicht (mehr)), werde die mal anfragen) aber auch bei TD in Luxemburg.

Gruß, praesens

[praesens]

Transparenz:

https://www.stockwatch.com/News/Item.aspx?bid=Z-C%3aCHV-2550…

Canada House lists intended uses for financing proceeds

2017-12-22 10:10 ET - News Release

Mr. Larry Bortles reports

CANADA HOUSE WELLNESS GROUP'S INTENDED USES OF FUNDS FROM RECENTLY CLOSED $8.6 MILLION CONVERTIBLE DEBENTURE UNIT FINANCING

Canada House Wellness Group Inc. has provided its intended uses for the $6,341,608 net new funds generated by its recent convertible debenture unit financing.

The schedule below notes that 4% of our private placement offering funds was paid in cash commissions; 22% was used to retire debt; 48% is intended to be used to complete the Pickering, ON Abba Medix grow facility to obtain its License to Sell and commence commercial sales; 15% will be used to expand the MFT operations; $450,000 for Knalysis Technologies R&D and the promotion of its CPM software subscriptions; and the balance will be added to the Company's working capital.


$ 8,609,000 100% Total Funds Raised

$ 1,700,000 20% Debt Retirements
$ 205,000 2% Payables Settlements
$ 362,392 4% Cash Commissions
$ 6,341,608 74% Net Funds to the Company

Intended uses of Net Funds to the Company
$ 4,100,000 48% Completion of Abba Medix Grow Facility
$ 1,300,000 15% Expansion of MFT Operations
$ 450,000 5% Knalysis R&D & Promotion
$ 491,608 6% Addition to Working Capital
$ 6,341,608 74% Total Planned Capital Uses

The Company's working capital balances are also being augmented by early warrant redemptions, which has totalled more than $700,000 during this month of December.

Canada House Wellness Group Inc.

Canada House is the parent company of Marijuana for Trauma Inc., Knalysis Technologies and Abba Medix Corp. The Company's goal is to become a marketplace leader through strategic partnerships, mergers, and acquisitions to create a fully integrated cannabis therapy company. For more information please visit http://www.canadahouse.ca . or www.sedar.com

We seek Safe Harbor.

© 2017 Canjex Publishing Ltd. All rights reserved."

[praesens]

Eine wichtige Info habe ich gestern unterschlagen:
Es gibt ein jv mit Nutritional High zur Herstellung von Ölen innerhalb des Abbamedix Gelaendes:

https://canadahouse.ca/2017/10/17/canada-house-is-pleased-to…

"Canada House is Pleased to Announce Its Joint Venture With Nutritional High, an Expert in Cannabis Oil Extracts and Edibles

TORONTO, Oct. 17, 2017 (GLOBE NEWSWIRE) — Canada House Wellness Group Inc.’s (“Canada House“) (CSE:CHV) wholly owned subsidiary Abba Medix Corp. (“Abba”) and Nutritional High International Inc. (“Nutritional High“) (CSE:EAT) (OTCQB:SPLIF) (FRANKFURT:2NU) have entered into a letter of intent (“LOI“) to create a joint venture (“Joint Venture”) to manufacture cannabis oil extracts and cannabis-infused products in Canada under the Access to Cannabis for Medical Purposes Regulations (Canada) (“ACMPR“).

Abba, a subsidiary of Canada House, and Nutritional High have agreed to form a Joint Venture company which will initially focus on building out an approximate 2,000 square foot area at Abba’s Pickering cannabis grow facility, to house a cannabis oil extraction operation focused on producing the oils and extracts currently permitted under ACMPR. As the Health Canada regulations continue to evolve, the Joint Venture will introduce additional products, all produced in accordance with Good Pharmacoepidemiology Practice guidelines so it can sell internationally.

Abba and Nutritional High expect the Joint Venture to open up new avenues of enterprise for both companies combining Canada House’s Canadian Licensing, its ability to supply trim and shake at a low cost, and introducing its burgeoning patient base to Nutritional High’s proven ability to extract top quality, high potency cannabis oil on a cost competitive basis.

..."

[praesens]

Power hour christmas rallye ...

[praesens]

Antwort auf Beitrag Nr.: 56.533.793 von praesens am 22.12.17 21:12:42

CHV wird m.E. weiter steigen.
Weil:
- "rundes" Geschäftsmodell (vertical Integration)
- sehr gut finanziert / "cash on hand"
- Patienten = Kunden vorhanden
- HC lizenziert.
- marketcap mit Lizenz geringer als die so einiger Lizenzanwaerter
- buy out Kandidat ?

Gruß, praesens

[Opa_Klaus]

Antwort auf Beitrag Nr.: 56.533.793 von praesens am 22.12.17 21:12:42

Bei MMJ sieht es heute auch nach Allzeithoch aus.

[praesens]

Antwort auf Beitrag Nr.: 56.533.898 von Opa_Klaus am 22.12.17 21:28:25

Ja, ist der Hammer. Hätte ich nicht so schnell so weit gesehen (... naja, MYM auch nicht ...). Wenn man bedenkt, dass MMJ vor einem Jahr noch bei 1/2 cent stand ...

Gruppe, praesens

[praesens]

... endlich über 50 cent.

Gruß, praesens

[Opa_Klaus]

Antwort auf Beitrag Nr.: 56.552.071 von praesens am 27.12.17 17:34:01

Der Anstieg von MMJ scheint wohl CHV mitzuziehen.

[praesens]

Antwort auf Beitrag Nr.: 56.552.203 von Opa_Klaus am 27.12.17 17:45:21

Ich würde mal sagen das ist der Marijuana-Sektor allgemein.

Und außerdem - vielleicht kann ich heute ja auch noch sagen "endlich 60 cent" ?!

Gruß, praesens

[Opa_Klaus]

Antwort auf Beitrag Nr.: 56.552.800 von praesens am 27.12.17 18:43:44

praesens, ich weiß nicht, irgendwie kommen mir die Kursanstiege nicht geheuer vor. Scheint so, als ob manche in Kanada ihr letztes Hemd verscherbeln oder Haus und Hof beleihen um in bestimmte Werte (Marijuana/BTC) noch schnell reinzukommen. Ob das 2018 so weiter geht? Ich hätte natürlich nichts dagegen.

[praesens]

Antwort auf Beitrag Nr.: 56.552.800 von praesens am 27.12.17 18:43:44

Endlich 60 cent ...

Gruß, praesens

[praesens]

Antwort auf Beitrag Nr.: 56.552.986 von Opa_Klaus am 27.12.17 19:09:28

Ich denke je näher wir dem Legalisierungsdatum kommen umso mehr wird der MMJ Sektor in Canada mainstream.
Die letzten beissen dann die Hunde. Aber soweit sind wir noch nicht denke ich.

Der blockchain Sektor könnte durch ganz 2018 gut laufen. Der Hype ist erst im Anfangsstadium.
Klar, blockchain und bitcoin sind zwei paar Schuhe, aber stell' Dir vor der bitcoin läuft in der Tat so hoch wie von einigen vorhergesagt ...

Gruß, praesens

[praesens]

Antwort auf Beitrag Nr.: 56.553.178 von praesens am 27.12.17 19:36:27

... abgesehen davon könnte 2018 ein gutes Jahr für die commodities werden: Öl, Metalle, Edelmetalle.

Gruß, praesens

[praesens]

Rennt weiter heute. Ich hatte leichte Zweifel, aber soll mir Recht sein:

[Opa_Klaus]

Vereinbarung über Joint Venture zwischen CHV und Nutritional High International Inc. (EAT)

https://globenewswire.com/news-release/2017/12/28/1275872/0/…

[praesens]

Antwort auf Beitrag Nr.: 56.562.922 von Opa_Klaus am 28.12.17 20:47:03

Quelle: siehe obiges post von Opa_Klaus:

"FLI Coming to Canada- Nutritional High and Canada House Announce the Signing of a Formal Joint Venture Agreement

TORONTO, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Nutritional High International Inc. ("Nutritional High") (CSE:EAT) (OTCQB:SPLIF) (FRANKFURT:2NU) and Canada House Wellness Group Inc.’s ("Canada House") (CSE:CHV) wholly owned subsidiary Abba Medix Corp. (“Abba”) (collectively the “Companies”) are pleased to announce that the Companies have entered into a definitive agreement in connection with the previously announced Joint Venture (“Joint Venture”) to manufacture cannabis oil extracts and cannabis-infused products in Canada under the Access to Cannabis for Medical Purposes Regulations ("ACMPR") (see press release dated October 18, 2017).

The Joint Venture is structured as a 50/50 partnership and will see Nutritional High and Abba build-out a production facility at Abba's Pickering facility to house a cannabis oil extraction operation focused on producing the oils and extracts currently permitted under ACMPR.

Nutritional High is working closely with Abba to secure a supplemental license from Health Canada for the production of medical cannabis oils. The Companies are looking forward to completing the facility build-out and servicing the Canadian medical cannabis market with alternative, more convenient and dose-controlled consumption methods. Once the appropriate regulatory frameworks are established, the Joint Venture will seek to service the Canadian recreational market as well.

Larry Bortles, Chairman of Canada House, commented: “This partnership provides our company with a platform to become one of the leading cannabis extracts companies in Canada and opens up opportunities to tap the global market for cannabis extracts.”

Jim Frazier, CEO of Nutritional High commented: “We are excited to be moving forward with the Joint Venture and look forward to working closely with Abba to replicate the operating model we’ve successfully deployed in the U.S.”

About Nutritional High International Inc.
Nutritional High is focused on developing, manufacturing and distributing premium and consistently dosed products in the cannabis-infused products industry, including edibles and oil extracts for nutritional, medical and adult recreational use. The Company works exclusively through licensed facilities in jurisdictions where such activity is permitted and regulated by state law.

For updates on the Company's activities and highlights of the Company's press releases and other media coverage, please follow Nutritional High on Facebook, Twitter, Instagram and Google+ or visit www.nutritionalhigh.com.

For further information, please contact:
David Posner, Chairman of the Board
Nutritional High International Inc.
647-985-6727
Email: [e-mail]

About Canada House Wellness Group Inc.
Canada House is the parent company of Marijuana for Trauma Inc., Knalysis Technologies and Abba Medix Corp. The Company's goal is to become a marketplace leader through strategic partnerships, mergers, and acquisitions to create a fully integrated cannabis therapy company. For more information please visit http://www.canadahouse.ca or www.sedar.com.

For further information, please contact:
Boom Capital Markets
Steve Low
647-620-5101
[e-mail]

..."

[Opa_Klaus]

Die Meldung hat dem Kurs gerade nochmal einen Schub über die 0,7 CAD gegeben.

[Opa_Klaus]

Antwort auf Beitrag Nr.: 56.563.204 von Opa_Klaus am 28.12.17 21:30:11

Puh, die letzte halbe Stunde geht's ja richtig zur Sache.

[praesens]

Antwort auf Beitrag Nr.: 56.563.204 von Opa_Klaus am 28.12.17 21:30:11

Zitat von Opa_Klaus: Die Meldung hat dem Kurs gerade nochmal einen Schub über die 0,7 CAD gegeben.

... welche 0,7 ...?

Gruß, praesens

[Opa_Klaus]

Antwort auf Beitrag Nr.: 56.563.432 von praesens am 28.12.17 21:58:52

sieht nach Schlusskurs 0,88 CAD aus.

[praesens]

https://globenewswire.com/news-release/2018/01/18/1296353/0/…

"Canada House Wellness Group Update on Abba Medix Grow Progress

January 18, 2018 08:29 ET | Source: Canada House Wellness Group Inc.

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

TORONTO, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Abba Medix Corp “Abba”, a subsidiary of Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) wishes to announce that it has been issued permits from Health Canada and the Canadian Food Inspection Agency to import its selected starting genetics.

These genetics are scheduled to arrive in February. Abba looks to have two lots of cannabis harvested and ready for Health Canada approval by the end of June and anticipates receiving a License to Sell by July. Abba then expects to be in full production by September of this year.

At full production, Abba’s current grow operations are projected to produce more than 2,100 kg annually.

..."

[praesens]

Antwort auf Beitrag Nr.: 56.756.790 von praesens am 18.01.18 15:34:47

https://www.stockwatch.com/News/Item.aspx?bid=Z-C%3aCHV-2559…

"ORIGINAL: Patient Growth Equals Big Data for Knalysis Technologies and Canada House Wellness Group

2018-01-22 08:39 ET - News Release

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

TORONTO, Jan. 22, 2018 (GLOBE NEWSWIRE) -- Knalysis Technologies “Knalysis”, a subsidiary of Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) wishes to announce that it now has more than 12,000 medical cannabis patients on its software platforms representing 6% of the registered base in all of Canada. Its clinicians are providing the best care possible to these patients through Knalysis’ sister division, Marijuana for Trauma, and their eleven clinics across Canada. Coupled with Knalysis’ US client base, more than 32 million data points for medical cannabis treatment have been captured to date.

As patient count in the Knalysis platforms continues to increase by approximately 2,500 per month, it is now seeing the impact of having big data at its fingertips. This information is critical to breaking away from anecdotal evidence of the efficacy of medical marijuana. It’s simply not good enough anymore to prescribe a treatment regimen based on what “we’ve heard” works. Patients deserve better and Knalysis platforms are ensuring that they’re getting it. Knalysis Technologies’ proprietary suite of software is helping clients grow their business through major efficiency gains and improving patient outcomes by interpreting and making good use of the significant amount of data that flows through its data platforms.

Knalysis is also gaining traction with several potential new cannabis clinic clients which would add another 10,000 – 20,000 patients into its platforms by mid-year, adding 10s of millions more data points for the benefit of its analytics subscribers. All of this strengthens Knalysis’ recommendations for patient treatments and their health outcomes. This vast amount of data has led to talks with key industry reporting partners and we expect more exciting news on this front very soon. All of this progress ultimately benefits patients who have been seeking the right kind of treatment for their ailments for decades. Getting away from anecdotal evidence and proving the efficacy of medical marijuana is the key to ensuring that access to this treatment is secured for the long term.

..."

[Opa_Klaus]

Eigentlich fand ich die beiden letzten Meldungen sehr gut. Es läuft soweit alles nach Plan.
Die Lizenz wird wahrscheinlich im Juli kommen und die Patientenanzahl hat sich auch erhöht.

Sehr schade, dass sich das bisher nicht im Kurs wiederspiegelt.

[praesens]

Betrifft CHV nicht wirklich - nur zur allgemeinen Info:

https://www.theglobeandmail.com/amp/news/politics/regulatory…

"Regulatory lag to push legal marijuana to late summer
...
Canadians will have to wait until late in the summer before they will be able to legally consume cannabis under a new timeline laid out by the federal government – even if the Senate votes in favour of the legislation by May or June ..."

[praesens]

Antwort auf Beitrag Nr.: 56.958.047 von praesens am 07.02.18 09:49:35

https://globenewswire.com/news-release/2018/03/09/1419918/0/…

"Innovations with Ed Begley Jr. to Feature Canada House’s Evidence-Based Cannabis Products & Services on Fox Business Innovations TV Series ..."

[praesens]

Antwort auf Beitrag Nr.: 56.958.047 von praesens am 07.02.18 09:49:35

https://globenewswire.com/news-release/2018/03/09/1419918/0/…

"Innovations with Ed Begley Jr. to Feature Canada House’s Evidence-Based Cannabis Products & Services on Fox Business Innovations TV Series ..."

[praesens]

Antwort auf Beitrag Nr.: 57.238.933 von praesens am 09.03.18 19:57:46

https://globenewswire.com/news-release/2018/04/23/1485430/0/…

"Abba Medix Receives its License to Produce Cannabis Oil

April 23, 2018 08:57 ET | Source: Canada House Wellness Group Inc.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES
OR DISSEMINATION IN THE UNITED STATES

TORONTO, April 23, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) is pleased to announce that:

Its Abba Medix Corp subsidiary has received from Health Canada its License to Produce Cannabis Oil; and
It will begin its cannabis cultivation on 1st May 2018.
Abba Medix President, Riley McGee asserted, “Receiving our License to Produce Cannabis Oil allows us to accelerate our recently announced joint venture with Nutritional High International Inc. to produce extract-based products approved for the Canadian market.” “I’d like to commend our Abba Medix team on the hard work required to obtain this important license,” he added.

The Company is also pleased to advise its shareholders that it has now received all of the required Health Canada approvals to begin cannabis cultivation on 1st May 2018 at our Abba Medix Pickering, ON facility.

..."

[praesens]

Antwort auf Beitrag Nr.: 57.617.433 von praesens am 24.04.18 17:32:00

https://globenewswire.com/news-release/2018/05/24/1511556/0/…

"The University of New Brunswick signs MOU with Canada House Wellness Group

May 24, 2018 08:30 ET | Source: Canada House Wellness Group Inc.

FREDERICTON, New Brunswick , May 24, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) is pleased to announce that it has signed a Memorandum of Understanding (MOU) with The University of New Brunswick (UNB) to provide researchers with opportunities to pursue the health benefits of cannabis.

“We’re excited to be working with Canada House’s team of medical, technological, scientific and business professionals to further build on UNB’s status as the leading academic and research-based university,” said Dr. David MaGee, vice-president of research at UNB.

“Our faculty and staff, combined with Canada House’s professionals, will lead the way in developing and executing multiple shared projects that will be at the forefront of this type of research.”

Canada House is a diversified group of companies with a broad range of expertise relating to the cannabis industry. Through the partnership, UNB and Canada House will provide researchers with opportunities to discover crucial information on the use of cannabis as a medicinal product. It will also allow for shared technology research and development and the exploration of shared education and outreach opportunities.

“We are pleased to be partnering with an academic institution of such high reputation, and rich history, as UNB,” said Larry Bortles, chair and CEO of Canada House. “As our industry continues to grow and expand, we are very excited at the potential of what we will accomplish together to change perceptions, not just in New Brunswick, but globally, of the efficacy of medicinal cannabis and it’s wide range of curative potential.”

The MOU continues UNB’s commitment to strengthening the provincial economy through innovative natural product research.

Potential areas of collaboration between Canada House and UNB include education, technology platforms, analytics and clinical and medical research, as well as plant research and genomics. A working group will be formed soon to identify and prioritize these research and educational projects.

“We are looking forward to starting work together immediately,” declared Dr. MaGee.

Canada House Wellness Group Inc.

Canada House is the parent company of Marijuana for Trauma Inc., Knalysis Technologies and Abba Medix Corp. The Company’s goal is to become a marketplace leader through strategic partnerships, mergers, and acquisitions to create a fully integrated cannabis therapy company. For more information please visit https://www.canadahouse.ca. or www.sedar.com.

About the University of New Brunswick

The University of New Brunswick (UNB) is Canada’s oldest English-language university. Founded in 1785, the multi-campus institution has a rich history and a dynamic focus on innovation, experiential learning and entrepreneurship. UNB has more than 10,500 students from nearly 100 countries while several thousand more take UNB courses online and at partner institutions around the world

..."

[praesens]

!!! Wichtig !!!
Alle die hier Aktien halten unbedingt lesen:

http://www.clearstream.com/clearstream-en/products-and-servi…

[praesens]

Antwort auf Beitrag Nr.: 58.059.280 von praesens am 25.06.18 11:20:38

Zum Thema:

https://www.wallstreet-online.de/nachricht/10674535-cannabis…

[praesens]

Antwort auf Beitrag Nr.: 58.079.038 von praesens am 27.06.18 14:27:00

http://www.stockhouse.com/news/press-releases/2018/07/17/can…

"Canada House Wellness Group Enters into Exclusive Licensing Agreement with Medicine Man Technologies for Canadian Deployment of its Intellectual Property and Product Lines

C.CHV | 8 hours ago
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

TORONTO, July 17, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. ("Canada House") or the ("Company") (CSE:CHV) is pleased to announce that it has entered into, through its wholly owned subsidiary Abba Medix Corp., an exclusive licensing agreement with Medicine Man Technologies Inc. (OTCQB:MDCL) (“Medicine Man”), one of the United States' leading cannabis branding and consulting companies, for deployment of its intellectual property and product lines (Three a Light ®, Success Nutrients ®, General Intellectual Property) into the Canadian marketplace.

The licensing agreement calls for payment of $4.65M (CAD) in the form of cash and stock for licensing of Medicine Man’s intellectual property, product lines, and assignment of an existing Cultivation MAX agreement to Canada House. Under the terms of the transaction, Canada House will pay cash consideration, of which $575,000 will be paid today, the effective date of the agreement, and $575,000 will be payable no later than November 30, 2018. The remaining payment will be satisfied by Canada House issuing to Medicine Man, within ten (10) business days of today, an aggregate of $3,500,000 worth of common shares in the capital of the Company based on the volume weighted average price of Canada House’s common shares for the five trading days ending on the effective date of the agreement. Furthermore, subject to applicable securities laws and the approval of the Canadian Securities Exchange (“CSE”), the Company and Medicine Man will exchange capital stock having an aggregate value of $1,000,000 in the form of a stock swap (the “Stock Swap”), which Stock Swap must be completed within 90 days of today, failing which, the Stock Swap will become null and void without affecting the other terms and conditions of the transaction. Subject to applicable securities laws and the approval of the CSE, the stock prices for the calculation of the number of Medicine Man and Canada House common shares for the Stock Swap will be the 5-day volume weighted average price, respectively, of the Medicine Man and Canada House common shares ending on the date of the Stock Swap. Medicine Man will also be entitled to revenue-based fees related to this deployment over the duration of the license agreement and will be assisting Canada House’s marketing efforts.

Medicine Man’s current CEO, Mr. Brett Roper and members of the Medicine Man team will be working extensively with the Canada House team to assist with transition and product development, in particular focusing on the deployment of a highly efficient network of newly announced micro-cultivator license types in Canada as well as other goods and service offerings.

Brett Roper, Medicine Man’s co-founder and CEO commented, “We are very excited to be aligning ourselves with the Canada House team as they focus on their growth and value goals in the Canadian Cannabis marketplace. In particular, this agreement provides potential future cost-based advantages to Canada House and craft based micro-cultivators in the evolving supply chain, providing a more viable financial basis. These types of opportunities facilitate the creation of additional jobs and infrastructure investments that will be very nimble and not tied down to any particular geographic area, also allowing for substantially less investment risk as we continue down this evolutionary path.”

“We are delighted to be working with Medicine Man, a leader in Cannabis grow technologies,” says Riley McGee, President of Abba Medix Corp. “By helping us improve our yields and quality, we believe that we will be a leading provider to the medical cannabis market and amongst one of the more sustainable and profitable companies in the industry. Our technology leadership will also be of immense benefit to the emerging micro-grower market.”

Chris Churchill-Smith, CEO of Canada House, added, “We are very excited to begin this important relationship with Medicine Man Technologies as the next step in the execution of our strategic plan under the guise of Canada House’s new and refreshed management team. We have experienced first-hand the benefits of the implementation of Medicine Man’s intellectual property and product lines within our Pickering, Ontario grow facility. We firmly believe that Medicine Man’s industry leading cultivation efficiency and performance have and will continue to provide us with a distinct advantage in achieving low cost production while achieving maximum efficiency and quality in our facility. We are excited to have the exclusive right to promote Medicine Man’s technology and products in Canada. This will provide extraordinary additional growth of our business lines and corresponding revenues. I want to thank both Riley and Brett, as well as the rest of his team at Medicine Man Technologies for their extensive work on bringing this project to fruition. We look forward to working closely together for many years to come."

Medicine Man Technologies, Inc.

Established in March 2014, Medicine Man Technologies secured its first client/licensee in April 2014. To date, Medicine Man Technologies has provided guidance for several clients that have successfully secured licenses to operate cannabis businesses within their state. Medicine Man Technologies currently has or has had active clients in California, Iowa, Oregon, Colorado, Nevada, Illinois, Michigan, Arkansas, Pennsylvania, Florida, Ohio, Maryland, New York, Massachusetts, Puerto Rico, Canada, Australia, Germany, and South Africa. They continue to focus on working with clients to 1) utilize its experience, technology, and training to help secure a license in states with newly emerging regulations, 2) deploy their highly effective variable capacity constant harvest cultivation practices through its deployment of Cultivation MAX, and eliminate the liability of single grower dependence, 3) avoid the costly mistakes generally made in start-up, 4) stay engaged with an ever expanding team of licensees and partners, all focused on quality and safety that will "share" the ever-improving experience and knowledge of the network, and 5) continuing the expansion of their Brands Warehouse concept through entry into industry based cooperative agreements and pursuing other acquisitions as they prove suitable to our overall business development strategy.

..."